Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$87.74 - $117.27 $46,326 - $61,918
-528 Reduced 38.71%
836 $81,000
Q4 2022

Feb 08, 2023

SELL
$80.93 - $108.63 $7,445 - $9,993
-92 Reduced 6.32%
1,364 $141,000
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $1,232 - $1,454
15 Added 1.04%
1,456 $124,000
Q2 2022

Aug 02, 2022

SELL
$71.48 - $86.85 $19,228 - $23,362
-269 Reduced 15.73%
1,441 $119,000
Q1 2022

Apr 28, 2022

BUY
$74.28 - $92.69 $2,822 - $3,522
38 Added 2.27%
1,710 $132,000
Q4 2021

Feb 15, 2022

SELL
$71.72 - $91.47 $59,957 - $76,468
-836 Reduced 33.33%
1,672 $148,000
Q3 2021

Nov 15, 2021

SELL
$74.77 - $85.47 $7,626 - $8,717
-102 Reduced 3.91%
2,508 $194,000
Q2 2021

Aug 09, 2021

SELL
$75.51 - $84.79 $4,983 - $5,596
-66 Reduced 2.47%
2,610 $218,000
Q1 2021

May 14, 2021

BUY
$74.73 - $90.69 $15,020 - $18,228
201 Added 8.12%
2,676 $202,000
Q4 2020

Feb 16, 2021

SELL
$72.61 - $90.2 $242,226 - $300,907
-3,336 Reduced 57.41%
2,475 $217,000
Q3 2020

Nov 13, 2020

BUY
$71.87 - $131.03 $304,944 - $555,960
4,243 Added 270.6%
5,811 $491,000
Q2 2020

Jul 20, 2020

SELL
$79.55 - $124.22 $337,530 - $527,065
-4,243 Reduced 73.02%
1,568 $193,000
Q1 2020

Jul 20, 2020

BUY
$71.37 - $96.85 $414,731 - $562,795
5,811 New
5,811 $491,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.